Oncology Institute Correlations
TOI Stock | USD 1.00 0.01 0.99% |
The current 90-days correlation between Oncology Institute and Medical Facilities is -0.02 (i.e., Good diversification). The correlation of Oncology Institute is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Oncology Institute Correlation With Market
Significant diversification
The correlation between Oncology Institute and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oncology Institute and DJI in the same portfolio, assuming nothing else is changed.
Oncology |
Moving together with Oncology Stock
Moving against Oncology Stock
0.69 | NHC | National HealthCare | PairCorr |
0.45 | ESPR | Esperion Therapeutics | PairCorr |
0.39 | INNV | InnovAge Holding Corp Earnings Call This Week | PairCorr |
0.38 | PNTG | Pennant Group | PairCorr |
0.31 | EHC | Encompass Health Corp Earnings Call This Week | PairCorr |
0.74 | 002382 | Blue Sail Medical | PairCorr |
0.68 | 600587 | Shinva Medical Instrument | PairCorr |
0.67 | 300981 | Zhonghong Pulin Medical | PairCorr |
0.65 | 300869 | Contec Medical Systems | PairCorr |
0.64 | 301370 | GKHT Medical Technology | PairCorr |
0.6 | DERM | Journey Medical Corp Upward Rally | PairCorr |
0.6 | 688198 | Beijing Balance Medical | PairCorr |
0.5 | LFCR | Lifecore Biomedical | PairCorr |
0.48 | AQST | Aquestive Therapeutics | PairCorr |
0.46 | 688139 | Qingdao Haier Biomedical | PairCorr |
0.43 | 688626 | Xiangyu Medical | PairCorr |
0.35 | 301367 | BMC Medical | PairCorr |
0.35 | VTI | Visioneering Technologies | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Oncology Stock performing well and Oncology Institute Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncology Institute's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RMYHY | 1.30 | (0.52) | 0.00 | 2.09 | 0.00 | 0.00 | 26.48 | |||
MFCSF | 1.20 | 0.08 | 0.00 | 1.30 | 1.11 | 3.58 | 7.68 | |||
JNHMF | 12.05 | 3.88 | 0.00 | 7.03 | 0.00 | 20.83 | 250.46 | |||
MCIOF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
FSNUY | 1.06 | 0.05 | 0.00 | 0.20 | 1.14 | 2.20 | 5.16 | |||
CANO | 4.54 | 0.40 | 0.04 | (0.31) | 4.70 | 11.11 | 36.13 | |||
LFST | 1.57 | 0.19 | 0.07 | 0.47 | 1.69 | 3.84 | 13.30 | |||
AGL | 5.41 | 0.70 | 0.08 | 1.33 | 7.81 | 11.56 | 39.93 | |||
PNTG | 1.66 | (0.29) | 0.00 | (1.93) | 0.00 | 3.76 | 8.51 | |||
BKD | 1.78 | (0.40) | 0.00 | (1.99) | 0.00 | 3.10 | 14.96 |
Oncology Institute Corporate Management
FACHE MD | Chief Officer | Profile | |
Mark Esq | General Counsel | Profile | |
Rob Carter | Senior Finance | Profile | |
Bradford Hively | CEO Director | Profile | |
Rakesh MBA | Director Technology | Profile | |
Laura Szitar | Chief Officer | Profile | |
Richard Barasch | Executive Board | Profile |